-transparent.png){kind=logo}
A group of 16 patients with chronic-progressing type of multiple sclerosis treated by intense immunosuppression (cyclophosphamide and ACTH) were followed-up for one year after completion of therapy. The results were compared with the observation of a control group of 16 patients with a similar type of multiple sclerosis. The choice of the type of therapy was done at random, and the results were assessed by a doctor who ignored the type of therapy used. In only a part of the observed cases stabilization of the disease process was observed, in a greater number in the cases treated with cyclophosphamide and ACTH than in the those treated with ACTH alone. However, the duration of follow-up is regarded as too short for reaching final conclusions regarding the effect of therapy on the course of this type of multiple sclerosis.
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
May 1991,
Journal of neuroimmunology,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
January 2002,
Revue neurologique,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
January 1987,
NITA,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
January 1988,
Annals of the New York Academy of Sciences,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
January 1988,
Neurologia i neurochirurgia polska,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
September 2001,
Revue neurologique,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
January 1986,
Neurologia i neurochirurgia polska,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
January 1975,
Clinical neurology and neurosurgery,
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
June 2005,
Multiple sclerosis (Houndmills, Basingstoke, England),
M Wender, and
E Tokarz-Kupczyk, and
O Mularek
January 1993,
Rinsho shinkeigaku = Clinical neurology,
